Lb Pharmaceuticals LBRX
NASDAQ LBRX
$39.36 +0.13 (+0.33%)
As of: Oct 22, 2026 · 11:37 AM EDT

Lb Pharmaceuticals (LBRX) Retained Earnings (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) recorded Retained Earnings of -$200.2 million in Q2 2026.

Analysis

Lb Pharmaceuticals (LBRX) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals reported Retained Earnings of -$129.53 million.

  • Across earlier years, Retained Earnings came in at -$104.32 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at -$148.6 million (Q1 2026), -$129.53 million (Q4 2025) and -$118.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn 171.67 Bn
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn -17.33 Bn
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn -
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn 12.59 Bn
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn 2.20 Bn
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn 112.09 Bn
10 Lb Pharmaceuticals 1.19 Bn -116.90 Mn - -200.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -200.20 Mn
Mar 31, 2026 -148.60 Mn
Dec 31, 2025 -129.53 Mn
Sep 30, 2025 -118.10 Mn
Dec 31, 2024 -104.32 Mn
API Access

Lb Pharmaceuticals Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=LBRX&period=max&api_key=YOUR_API_KEY